The US Bankruptcy Court gave an order approving the amended bidding procedures relating to the sale of certain assets of Generex Biotechnology Corporation on January 10, 2023. As per the amended bidding procedure approval, bidding deadline has been extended to January 20, 2023. The auction is scheduled for January 30, 2023.

The sale hearing is scheduled for January 31, 2023.